Page URL: https://www.bionews.org.uk/page_89265

Gene affects embryo's need for folic acid

21 May 2004
By BioNews
Appeared in BioNews 259

A new study confirms the need for women planning a pregnancy to take folic acid supplements, in order to reduce the risk of serious congenital conditions in their babies. A team of Irish and US researchers has found that around half the population inherit a genetic variation linked to an increased risk of spina bifida and other neural tube defects. However, they say that taking 400mg of folic acid a day, for at least a month before becoming pregnant and during early pregnancy, cancels out this genetic risk.

Between the third and fourth weeks of a human embryo's life, a groove running along its length folds up to make a cylinder called the neural tube, which later grows into the brain and spinal cord. Women trying to conceive are advised to take folic acid daily until the 12th week of pregnancy, because folate (the natural form of folic acid) is essential for this process. Taking folic acid reduces the risk of neural tube defects such as spina bifida and anencephaly, conditions in which the neural tube hasn't closed properly. However, many different genetic and non-genetic factors are thought to trigger these conditions.

Previous research showed that babies who inherit two copies of the 'T' version of the MTHFR gene, which is involved in processing folate, have an increased risk of being born with a neural tube defect. The new study, published online in the British Medical Journal, suggests that those who inherit just one T gene, along with a normal 'C' version, are also more likely to be affected. The 'CT' combination of gene variants appears to increase the risk of neural tube defects by about 50 per cent, whereas the risk for 'TT' individuals is more than double the average. The researchers, based in Dublin, studied 395 affected individuals, aged between five months and 52 years, and 848 healthy people.

The scientists estimate that around 38 per cent of the population inherit the CT gene combination, and ten per cent inherit two T versions. Taken together, they say that the T version of the MTHFR gene accounts for around a quarter of all cases of neural tube defects. But taking folic acid before and during pregnancy appears to cancel out the effects of the T gene variant. Lead author Peadar Kirke, of Dublin's Health Research Board, said: 'This is a rare situation where there is a potential problem during pregnancy, but it can easily be corrected'. He called for flour products to be fortified with folic acid, saying that Europe is 'lagging behind in a very serious negative way in not fortifying food'.

SOURCES & REFERENCES
Half UK Population at Increased Risk of Neural Tube Effects
Medical News Today |  21 May 2004
More Women at Risk for Birth Defects Than Thought
HealthDay News |  20 May 2004
Raised birth defect risk common
BBC News Online |  20 May 2004
Study Boosts Case for Folic Acid Supplements
Yahoo Daily News |  21 May 2004
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
30 October 2006 - by Dr Laura Bell 
A Harvard Medical school study involving 18,000 women has shown that taking multivitamins, particularly folic acid, can improve chances of pregnancy in couples having difficulty conceiving. Around 150,000 couples in the UK suffer from infertility problems due to the woman's inability to ovulate, which is about 1...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.